Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

The Cluster of Excellence PMI will receive funding for another seven years, enabling it to continue its successful research into chronic inflammatory diseases.

With light installations and a music video, the Cluster of Excellence PMI and Kiel University are drawing attention to chronic inflammatory bowel diseases and the associated need for research.

Placebo-controlled clinical trial with 900 COVID-19 patients shows success of a new patent-protected compound from the Cluster of Excellence PMI in Kiel (Germany).

In a data sharing statement, university medicine in Kiel and Lübeck commits to providing its clinical study data differentiated by gender and diversity characteristics.